249 related articles for article (PubMed ID: 12228912)
1. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
Buendia MA
Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
4. Genetics of hepatocellular carcinoma.
Buendia MA
Semin Cancer Biol; 2000 Jun; 10(3):185-200. PubMed ID: 10936068
[TBL] [Abstract][Full Text] [Related]
5. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
Weber RG; Pietsch T; von Schweinitz D; Lichter P
Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
[TBL] [Abstract][Full Text] [Related]
6. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
[TBL] [Abstract][Full Text] [Related]
7. Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis.
Nishida N; Nishimura T; Nagasaka T; Ikai I; Goel A; Boland CR
Cancer Res; 2007 May; 67(10):4586-94. PubMed ID: 17510384
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization.
Terracciano L; Tornillo L
Pathologica; 2003 Apr; 95(2):71-82. PubMed ID: 12768875
[TBL] [Abstract][Full Text] [Related]
10. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
[TBL] [Abstract][Full Text] [Related]
11. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T
J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
[TBL] [Abstract][Full Text] [Related]
14. Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability.
Guda K; Upender MB; Belinsky G; Flynn C; Nakanishi M; Marino JN; Ried T; Rosenberg DW
Oncogene; 2004 May; 23(21):3813-21. PubMed ID: 15021908
[TBL] [Abstract][Full Text] [Related]
15. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array.
Park SJ; Jeong SY; Kim HJ
Cancer Genet Cytogenet; 2006 Apr; 166(1):56-64. PubMed ID: 16616112
[TBL] [Abstract][Full Text] [Related]
16. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.
Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO
Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286
[TBL] [Abstract][Full Text] [Related]
17. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
18. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.
Katoh H; Ojima H; Kokubu A; Saito S; Kondo T; Kosuge T; Hosoda F; Imoto I; Inazawa J; Hirohashi S; Shibata T
Gastroenterology; 2007 Nov; 133(5):1475-86. PubMed ID: 17983802
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanism of hepatocarcinogenesis].
Imazeki F; Saisho H
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
[TBL] [Abstract][Full Text] [Related]
20. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
Kim Y; Sills RC; Houle CD
Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
